Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Rockwell Medical, Inc. (RMTI) since 2013 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Rockwell Medical, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1041024.
Total stock buying since 2013: $1,295,768.
Total stock sales since 2013: $1,495,209.
Total stock option exercises since 2013: $5,678,637.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 87,500 | $93,675 | 23,523 | $24,751 | 0 | $0 |
| 2024 | 0 | $0 | 33,155 | $82,436 | 0 | $0 |
| 2020 | 26,681 | $51,967 | 842,450 | $880,719 | 0 | $0 |
| 2019 | 206,551 | $639,055 | 179 | $558 | 0 | $0 |
| 2018 | 5,554,123 | $56,586 | 0 | $0 | 5,000 | $15,450 |
| 2017 | 37,815 | $221,326 | 6,036 | $36,133 | 487,500 | $3,168,750 |
| 2016 | 0 | $0 | 44,945 | $267,960 | 25,000 | $77,250 |
| 2015 | 20,000 | $233,159 | 19,109 | $196,618 | 531,250 | $2,417,187 |
| 2013 | 0 | $0 | 1,325 | $6,034 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 0 | $0 | 10,680 | $8,756 | 0 | $0 |
| 2025-04 | 87,500 | $93,675 | 10,680 | $11,551 | 0 | $0 |
| 2025-01 | 0 | $0 | 2,163 | $4,444 | 0 | $0 |
| 2024-11 | 0 | $0 | 29,991 | $70,778 | 0 | $0 |
| 2024-10 | 0 | $0 | 3,164 | $11,658 | 0 | $0 |
| 2020-12 | 0 | $0 | 842,450 | $880,719 | 0 | $0 |
| 2020-06 | 24,681 | $47,807 | 0 | $0 | 0 | $0 |
| 2020-05 | 2,000 | $4,160 | 0 | $0 | 0 | $0 |
| 2019-08 | 97 | $234 | 0 | $0 | 0 | $0 |
| 2019-07 | 185,942 | $549,222 | 179 | $558 | 0 | $0 |
| 2019-06 | 10,000 | $30,600 | 0 | $0 | 0 | $0 |
| 2019-05 | 4,643 | $26,209 | 0 | $0 | 0 | $0 |
| 2019-03 | 5,869 | $32,790 | 0 | $0 | 0 | $0 |
| 2018-10 | 5,541,562 | $0 | 0 | $0 | 0 | $0 |
| 2018-09 | 0 | $0 | 0 | $0 | 5,000 | $15,450 |
| 2018-06 | 12,561 | $56,586 | 0 | $0 | 0 | $0 |
| 2017-12 | 0 | $0 | 36 | $235 | 487,500 | $3,168,750 |
| 2017-08 | 605 | $3,836 | 0 | $0 | 0 | $0 |
| 2017-03 | 37,210 | $217,490 | 6,000 | $35,898 | 0 | $0 |
| 2016-11 | 0 | $0 | 21,125 | $110,050 | 0 | $0 |
| 2016-10 | 0 | $0 | 2,533 | $15,299 | 0 | $0 |
| 2016-09 | 0 | $0 | 8,075 | $54,976 | 0 | $0 |
| 2016-08 | 0 | $0 | 4,827 | $34,811 | 0 | $0 |
| 2016-02 | 0 | $0 | 8,385 | $52,824 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-01 | Chole Timothy (SVP and CCO) | Sale | 2,868 | .82 | 2,351 |
| 2025-07-01 | Neri Jesse (SVP and CFO) | Sale | 886 | .82 | 726 |
| 2025-07-01 | Strobeck Mark (President and CEO) | Sale | 6,926 | .82 | 5,679 |
| 2025-04-11 | Irrevocable Larson Family Investment Trust (10% Owner) | Buy | 30,500 | 1.08 | 32,970 |
| 2025-04-10 | Irrevocable Larson Family Investment Trust (10% Owner) | Buy | 57,000 | 1.06 | 60,705 |
| 2025-04-01 | Chole Timothy (SVP, Chief Commercial Officer) | Sale | 2,868 | 1.08 | 3,097 |
| 2025-04-01 | Neri Jesse (SVP, FINANCE AND CFO) | Sale | 886 | 1.10 | 974 |
| 2025-04-01 | Strobeck Mark (President and CEO) | Sale | 6,926 | 1.08 | 7,480 |
| 2025-01-02 | Strobeck Mark (President and CEO) | Sale | 2,163 | 2.06 | 4,444 |
| 2024-11-15 | Ravich Mark H | Sale | 29,991 | 2.36 | 70,778 |
| 2024-10-01 | Chole Timothy (SVP, Chief Commercial Officer) | Sale | 1,001 | 3.69 | 3,688 |
| 2024-10-01 | Strobeck Mark (President and CEO) | Sale | 2,163 | 3.69 | 7,970 |
| 2020-12-21 | Curfman Matthew J. | Sale | 42,450 | 1.03 | 43,723 |
| 2020-12-16 | Curfman Matthew J. | Sale | 521,876 | 1.02 | 530,226 |
| 2020-12-15 | Curfman Matthew J. | Sale | 278,124 | 1.10 | 306,770 |
| 2020-06-30 | Rbi Opportunities Fund Ii, Llc | Buy | 24,681 | 1.94 | 47,807 |
| 2020-05-14 | Ellison Russell H (See Remarks) | Buy | 2,000 | 2.08 | 4,160 |
| 2019-08-02 | Rbi Opportunities Fund Ii, Llc | Buy | 97 | 2.42 | 234 |
| 2019-07-31 | Rbi Opportunities Fund Ii, Llc | Buy | 1,807 | 2.66 | 4,806 |
| 2019-07-29 | Curfman Matthew J. | Sale | 179 | 3.12 | 558 |
| 2019-07-25 | Rbi Opportunities Fund Ii, Llc | Buy | 319 | 3.06 | 975 |
| 2019-07-24 | Rbi Opportunities Fund Ii, Llc | Buy | 2,579 | 3.13 | 8,072 |
| 2019-07-22 | Rbi Opportunities Fund Ii, Llc | Buy | 92,707 | 2.99 | 277,193 |
| 2019-07-19 | Rbi Opportunities Fund Ii, Llc | Buy | 68,750 | 2.89 | 198,687 |
| 2019-07-08 | Rbi Opportunities Fund Ii, Llc | Buy | 9,780 | 3.05 | 29,789 |
| 2019-07-01 | Paul Stuart M (Chief Executive Officer) | Buy | 10,000 | 2.97 | 29,700 |
| 2019-06-28 | Smith Angus W. (Chief Financial Officer) | Buy | 10,000 | 3.06 | 30,600 |
| 2019-05-09 | Rbi Opportunities Fund Ii, Llc | Buy | 4,643 | 5.64 | 26,209 |
| 2019-03-27 | Rbi Opportunities Fund Ii, Llc | Buy | 5,869 | 5.59 | 32,790 |
| 2018-10-15 | Curfman Matthew J. | Buy | 5,541,562 | .00 | 0 |
| 2018-09-20 | Kull David (Principal Accounting Officer) | Option Ex | 5,000 | 3.09 | 15,450 |
| 2018-06-28 | Curfman Matthew J. | Buy | 7,940 | 4.37 | 34,729 |
| 2018-06-27 | Curfman Matthew J. | Buy | 4,621 | 4.73 | 21,857 |
| 2017-12-15 | Curfman Matthew J. | Sale | 36 | 6.53 | 235 |
| 2017-12-15 | Bagley Patrick J (Director) | Option Ex | 50,000 | 6.50 | 325,000 |
| 2017-12-15 | Boyd Ronald D (Director) | Option Ex | 25,000 | 6.50 | 162,500 |
| 2017-12-15 | Klema Thomas E (Vice President, CFO) | Option Ex | 87,500 | 6.50 | 568,750 |
| 2017-12-15 | Chioini Robert L (Chairman, President and CEO) | Option Ex | 325,000 | 6.50 | 2,112,500 |
| 2017-08-10 | Curfman Matthew J. | Buy | 605 | 6.34 | 3,836 |
| 2017-03-22 | Curfman Matthew J. | Buy | 21,076 | 5.94 | 125,107 |
| 2017-03-21 | Curfman Matthew J. | Buy | 16,134 | 5.73 | 92,383 |
| 2017-03-16 | Holt Kenneth L (Director) | Sale | 6,000 | 5.98 | 35,898 |
| 2016-11-11 | Holt Kenneth L (Director) | Sale | 13,725 | 5.35 | 73,442 |
| 2016-11-09 | Holt Kenneth L (Director) | Sale | 6,000 | 4.72 | 28,320 |
| 2016-11-01 | Holt Kenneth L (Director) | Sale | 1,400 | 5.92 | 8,288 |
| 2016-10-21 | Holt Kenneth L (Director) | Sale | 1,583 | 6.10 | 9,656 |
| 2016-10-19 | Holt Kenneth L (Director) | Sale | 950 | 5.94 | 5,643 |
| 2016-09-19 | Holt Kenneth L (Director) | Sale | 4,570 | 6.83 | 31,213 |
| 2016-09-16 | Holt Kenneth L (Director) | Sale | 3,505 | 6.78 | 23,763 |
| 2016-08-25 | Holt Kenneth L (Director) | Sale | 1,135 | 6.90 | 7,831 |
| 2016-08-16 | Holt Kenneth L (Director) | Sale | 1,362 | 7.33 | 9,983 |
| 2016-08-12 | Holt Kenneth L (Director) | Sale | 2,330 | 7.29 | 16,997 |
| 2016-02-12 | Holt Kenneth L (Director) | Sale | 4,550 | 6.46 | 29,393 |
| 2016-02-09 | Holt Kenneth L (Director) | Sale | 3,835 | 6.11 | 23,431 |
| 2016-01-15 | Holt Kenneth L (Director) | Option Ex | 25,000 | 3.09 | 77,250 |
| 2015-12-15 | Klema Thomas E (Vice President, CFO) | Option Ex | 93,750 | 4.55 | 426,562 |
| 2015-12-11 | Bagley Patrick J (Director) | Option Ex | 25,000 | 4.55 | 113,750 |
| 2015-12-11 | Chioini Robert L (Chairman, President and CEO) | Option Ex | 375,000 | 4.55 | 1,706,250 |
| 2015-12-04 | Boyd Ronald D (Director) | Sale | 12,500 | 10.59 | 132,412 |
| 2015-12-04 | Boyd Ronald D (Director) | Option Ex | 12,500 | 4.55 | 56,875 |
| 2015-11-11 | Holt Kenneth L (Director) | Option Ex | 25,000 | 4.55 | 113,750 |
| 2015-10-15 | Holt Kenneth L (Director) | Sale | 470 | 8.53 | 4,009 |
| 2015-10-09 | Holt Kenneth L (Director) | Sale | 2,007 | 8.27 | 16,597 |
| 2015-10-02 | Holt Kenneth L (Director) | Sale | 1,430 | 8.10 | 11,585 |
| 2015-09-01 | Holt Kenneth L (Director) | Sale | 2,192 | 11.90 | 26,084 |
| 2015-08-24 | Holt Kenneth L (Director) | Sale | 510 | 11.63 | 5,931 |
| 2015-08-14 | Chioini Robert L (Chairman, President and CEO) | Buy | 4,910 | 11.96 | 58,723 |
| 2015-08-13 | Pratt Raymond Dennis (VP of Drug Development) | Buy | 5,000 | 11.54 | 57,690 |
| 2015-08-13 | Gupta Ajay (Chief Scientific Officer) | Buy | 5,000 | 11.62 | 58,125 |
| 2015-08-13 | Chioini Robert L (Chairman, President and CEO) | Buy | 5,090 | 11.52 | 58,621 |
| 2013-07-13 | Holt Kenneth L (Director) | Sale | 1,325 | 4.55 | 6,034 |
Insider trading activities including stock purchases, stock sales, and option exercises of RMTI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Rockwell Medical, Inc. (symbol RMTI, CIK number 1041024) see the Securities and Exchange Commission (SEC) website.